A confirmed case of systemic lupus erythematosus (SLE) with lupus associated nephritis has been admitted to the hospital. The follow-up ELISA to detect various autoantibodies suggests very high titres of anti-C1q autoantibodies. Explain How would you design your C1q-dependent haemolytic assay using this patient’s serum? How would you explain your results if you achieve a normal CH50 value? How would you explain your results if you fail to achieve a CH50 value

A confirmed case of systemic lupus erythematosus (SLE) with lupus associated nephritis has been admitted to the hospital. The follow-up ELISA to detect various autoantibodies suggests very high titres of anti-C1q autoantibodies. Explain How would you design your C1q-dependent haemolytic assay using this patient’s serum? How would you explain your results if you achieve a normal CH50 value? How would you explain your results if you fail to achieve a CH50 value

Curren'S Math For Meds: Dosages & Sol

11th Edition

ISBN:9781305143531

Author:CURREN

Publisher:CURREN

Chapter14: Formula Method

Section: Chapter Questions

Problem 34SST

See similar textbooks

Similar questions

Please help explain Angiotensin-converting enzyme 2 (ACE2) is a receptor for cell entry of SARS-CoV-2, and recombinant soluble ACE2 protein inhibits SARS-CoV-2 infection as a decoy. ACE2 is a carboxypeptidase that degrades angiotensin II, thereby improving the pathologies of cardi- ovascular disease or acute lung injury. Here we show that B38-CAP, an ACE2-like enzyme, is protective against SARS-CoV-2-induced lung injury. Endogenous ACE2 expression is downregulated in the lungs of SARS-CoV-2-infected hamsters, leading to elevation of angiotensin II levels. Recombinant Spike also downregulates ACE2 expression and worsens the symptoms of acid-induced lung injury. B38-CAP does not neutralize cell entry of SARS- CoV-2. However, B38-CAP treatment improves the pathologies of Spike-augmented acid- induced lung injury. In SARS-CoV-2-infected hamsters or human ACE2 transgenic mice, B38-CAP signi!cantly improves lung edema and pathologies of lung injury. These results provide the !rst in vivo…
The first table is known, and the second is unknown. we are trying to determine by ELISA if unknown samples (1 & 2) contain antibodies for chicken gamma globulin antigen, which sample contain the antigen? •Create Fig 1 -Draw a standard curve using the semilog graph paper. Remember, your X-axis is your absorbance at 655nm (linear scale), and your Y-axis is your concentration in ng/ml (log scale) •Show the concentrations of unknowns (how you find them by drawing vertical lines) in Fig 1. Please label the negative and positive control and the unkown 1 and 2.
Please answer fast what is the most likely cause of this patirecent onset of recurrent UTI? what is the most likely cause of the positive bulirubin result for this patient?
Please answer both asap If there were only 2 tests for COVID-19 and Test A has a high sensitivity but low specificity while Test B has low sensitivity and high specificity, which test would you choose and why? -A Covid-19 diagnostic test has a sensitivity of 80%. What would be the percentage of false negatives for the test?
In relation to immunotechnology, answer the following: A- Answer the following in relation to Hybridoma technology: → What is the cancer cell line name used in hybridoma technology? → Give an example of murine Monocolonal Antibody produced by hybridoma technology? B- Give ONE main difference between: Murine MABs and fully human MABs? and explain the reason behind developing different forms of Monoclonal antibodies (chimeric MABs, humanized MABs, and fully human MABs) C- You are in an internship in one major Hospital, You were in rotation with a clinical pharmacist in oncology section and you came over a breast cancer patient. The personal doctor was making a quick visit to the patient to make sure the patient is following the therapeutic protocol and the treatment is running smoothly. The doctor wrote in the prescription sheet “Trastuzumab” to be dispensed by the In Patient Pharmacy, when the clinical pharmacist saw this he advised the doctor politely to use the…
Discuss and explain the results of this graph. Graph shows results of WST-1 assay. T0 ( time zero) shows assay performed in order to obtain an absorbance at the time of test agent added in order to determine 1. how much cells have grown over the incubation period 2. Growth inhibition by test agent 3. If test agent caused cytotoxicity
Please answer fast and Immunocompromised patients have a weakened immune system and are more likely to get severe infection. For instance, the mortality rate of the immunocompromised patients with respiratory compromise are estimated between 30% and 90%. (a) Explain the issues in control of infection for critical and immunocompromised patients in hospital. (b) Discuss the control measures in reducing the risk of infection among the critical and immunocompromised patients in hospital.
You have the following reagents available Rat anti-Keratin 8 antibody specific for mouse Keratin 8, Rabbit polyclonal antibody against mouse keratin 5 and antifade reagent with DAPI to stain DNA. Both primary antibodies work best at 1:500 dilution. A) What additional reagents would you need to perform immunostaining of frozen sections of mouse thymus tissue for Keratin 8 that is expressed in cortical thymic epithelial cells and Keratin 5 that is expressed in mouse medullary thymic epithelial cells? B) Create a staining protocol including all tubes and appropriate controls to stain 4 slides with frozen thymic sections. You will need 200ul of antibody staining solution for each slide.
You are solving for an unknown blood type. Drops of blood have been mixed with solutions containing the antibodies Anti- A, Anti-B and Anti-Rh. The test results are are pictured below. Using your knowledge of antibody- antigen interactions and the principle of agglutination, identify the blood type and answer the associated questions
Explain why haematopoetic stem cell transplantation (HSCT) can be a curativetreatment for some forms of immunodeficiency. As part of your answer giveexamples of congenital and acquired immunodeficiencies that can be treated withHSCT
It was mentioned to do Biocompatibility Testing to ensure the TPU scaffold and encapsulated beta cells won't trigger an immune response or adverse reactions. Can you explain the testing process in more detail please.
An MLS student on her clinical rotation is running an immunofixation electrophoresis procedure on a 49 yo. male. She notes something peculiar in the total serum protein lane or in some systems this is called the SPE lane. In this lane, there is no band where albumin should be. All of the other bands are present. She checks the patient’s chemistry profile to find that his serum albumin is in the normal range.1. Is albumin an anion or cation?2. Which direction should albumin move during electrophoresis, toward the anode or cathode?3. What possible reason or reasons would cause the albumin not to show up on the gel?4. Should the test be repeated and if so how should it be done differently?5. Is it possible that the patient’s Iiver does not produce albumin due to chronic liver disease and that is why it did not show up on the SPE?